Advanced in Plasmacytoma

Dr. Archie W. Wright

Hematology Oncology | Hematology | Oncology
Jackson-Madison County General Hospital
650 Nuckolls Rd, 
Bolivar, TN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Advanced in Plasmacytoma
Jackson-Madison County General Hospital
650 Nuckolls Rd, 
Bolivar, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Archie Wright is a Hematologist Oncology specialist and a Hematologist in Bolivar, Tennessee. Dr. Wright is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Lynch Syndrome, and Colorectal Cancer. Dr. Wright is currently accepting new patients.

His clinical research consists of participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Kansas City Homeopathic Medical College
Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MS
Hospital Affiliations
Volunteer Community Hospital
Jackson-Madison County General Hospital
Dyersburg Regional Medical Center
West Tennessee Healthcare Henry County Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

JACKSON-MADISON COUNTY GENERAL HOSPITAL
650 Nuckolls Rd, Bolivar, TN 38008
Other Locations
JACKSON-MADISON COUNTY GENERAL HOSPITAL
620 Skyline Dr, Jackson, TN 38301

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Recruiting
Publish Date: July 03, 2024
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: October 06, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Drug
Study Drug: Lenalidomide
Study Phase: Phase 3
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate
Study Phase: Phase 3
Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Other
Study Phase: Phase 3
View 7 Less Clinical Trials
Similar Doctors
Advanced in Plasmacytoma
Dr. Jason Chandler
Hematology | Oncology
Advanced in Plasmacytoma
Dr. Jason Chandler
Hematology | Oncology

The West Clinic, PLLC

2001 State Dr, 
Corinth, MS 
 (33.8 miles away)
662-286-3694
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jason Chandler is a Hematologist and an Oncologist in Corinth, Mississippi. Dr. Chandler is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Non-Hodgkin Lymphoma, Multiple Myeloma, Lung Cancer, Bone Marrow Aspiration, and Bone Marrow Transplant.

Advanced in Plasmacytoma
Dr. Joseph E. Fouche
Oncology | Hematology
Advanced in Plasmacytoma
Dr. Joseph E. Fouche
Oncology | Hematology

Jackson-Madison County General Hospital

620 Skyline Dr, 
Jackson, TN 
 (27.4 miles away)
731-541-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Fouche is an Oncologist and a Hematologist in Jackson, Tennessee. Dr. Fouche is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Non-Hodgkin Lymphoma. Dr. Fouche is currently accepting new patients.

Advanced in Plasmacytoma
Dr. Gregory B. Franz
Oncology | Hematology
Advanced in Plasmacytoma
Dr. Gregory B. Franz
Oncology | Hematology

Jackson-Madison County General Hospital

620 Skyline Dr, 
Jackson, TN 
 (27.4 miles away)
731-541-5000
Languages Spoken:
English, Afar
See accepted insurances
Accepting New Patients
Offers Telehealth

Gregory Franz is an Oncologist and a Hematologist in Jackson, Tennessee. Dr. Franz is rated as a Distinguished provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Thrombocytopenia, and Large-Cell Lung Carcinoma. Dr. Franz is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wright's expertise for a condition
ConditionClose
    View All 21 Distinguished Conditions
    View All 57 Advanced Conditions
    View All 136 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile